SCHEMBL6176909

SCHEMBL6176909

O=S(=O)(c1ccc(Br)cc1)N1CCCC1c1ccc(F)cc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.86
PSEN1 P49768 1/20 0.52
PSEN2 P49810 1/20 0.52
APH1B Q8WW43 1/20 0.52
NCSTN Q92542 1/20 0.52
APH1A Q96BI3 1/20 0.52
PSENEN Q9NZ42 1/20 0.52
LMNA P02545 4/20 0.52
HTT P42858 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
TSHR P16473 2/20 0.49
MAPT P10636 4/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
S1PR2 O95136 1/20 0.46
S1PR4 O95977 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176913 1.00 TRPA1 (0.86) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178865 0.93 TRPA1 (1.00) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178870 0.93 TRPA1 (1.00) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6177006 0.86 TRPA1 (0.86) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL3731910 0.86 TRPA1 (0.86) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6177808 0.86 TRPA1 (0.86) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL3731913 0.86 TRPA1 (0.86) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178197 0.86 TRPA1 (0.86) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6177865 0.86 TRPA1 (0.86) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6177805 0.86 TRPA1 (0.86) TRPA1PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
EP-1165510-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-02 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed
WO-2000058285-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-10-05 WO disclosed